FDA Drug Application (203076) for LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE by CIPLA LTD

Back to FDA Applications sponsored by CIPLA LTD

Application Number203076
Product Number001
FormTABLET; ORAL SUSPENSION
Dosage30MG; 50MG; 60MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
Active IngredientLAMIVUDINE; NEVIRAPINE; ZIDOVUDINE



Back to FDA Applications sponsored by CIPLA LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.